Background: Radioiodine therapy (131I) forms a principal cornerstone in the management of differentiated thyroid cancer. Radioiodine-refractory differentiated thyroid cancer (RAIR-DTC) presents a c... Click to show full abstract
Background: Radioiodine therapy (131I) forms a principal cornerstone in the management of differentiated thyroid cancer. Radioiodine-refractory differentiated thyroid cancer (RAIR-DTC) presents a c...
               
Click one of the above tabs to view related content.